Somatic deletion of the NFI gene in a neurofibromatosis type 1-associated malignant melanoma demonstrated by digital PCR

Molecular Cancer

Volumn 5, Issue , 2006, Pages

  Rübben, Albert ^a   Bausch, Birke ^b   Nikkels, Arjen ^c  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

^c UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

FORMALDEHYDE; NEUROFIBROMIN; DNA; MICROSATELLITE DNA;

ADOLESCENT; ARTICLE; CASE REPORT; CELL ISOLATION; DISEASE ASSOCIATION; GENE DELETION; GENE INACTIVATION; GENE LOSS; GENE MUTATION; HETEROZYGOSITY LOSS; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; LASER MICRODISSECTION; MALE; MELANOMA; MELANOMA CELL; MICROSATELLITE MARKER; NEUROFIBROMATOSIS; POLYMERASE CHAIN REACTION; PROBABILITY; SKIN CARCINOGENESIS; STATISTICAL SIGNIFICANCE; TISSUE FIXATION; TUMOR PROMOTION; VERTICAL TRANSMISSION; ALLELE; CHEMISTRY; CHROMOSOME 17; GENETICS; METHODOLOGY; NUCLEOTIDE SEQUENCE; PATHOLOGY;

ADOLESCENT; ALLELES; CHROMOSOMES, HUMAN, PAIR 17; DNA MUTATIONAL ANALYSIS; DNA, NEOPLASM; GENE DELETION; HUMANS; LOSS OF HETEROZYGOSITY; MALE; MELANOMA; MICROSATELLITE REPEATS; NEUROFIBROMATOSIS 1; NEUROFIBROMIN 1; POLYMERASE CHAIN REACTION;

EID: 33748986055     PISSN: 14764598     EISSN: 14764598     Source Type: Journal    
DOI: 10.1186/1476-4598-5-36     Document Type: Article

References (44)

1. Riccardi VM: Neurofibromatosis: Phenotype, natural history, and pathogenesis Baltimore: The Johns Hopkins University Press; 1992.
2. Lammert M, Friedman JM, Kluwe L, Mautner VF: Prevalence of neurofibromatosis 1 in German children at elementary school enrollment. Arch Dermatol 2005, 141:71-74.
3. Xu GF, O'Connell P, Viskochil D, Cawthon R, Robertson M, Culver M, Dunn D, Stevens J, Gesteland R, White R, et al.: The neurofibromatosis type 1 gene encodes a protein related to GAP. Cell 1990, 62:599-608.
4. Legius E, Marchuk DA, Collins FS, Glover TW: Somatic deletion of the neurofibromatosis type 1 gene in a neurofibrosarcoma supports a tumour suppressor gene hypothesis. Nat Genet 1993, 3:122-126.
5. Xu W, Mulligan LM, Ponder MA, Liu L, Smith BA, Mathew CG, Ponder BA: Loss of NF1 alleles in phaeochromocytomas from patients with type 1 neurofibromatosis. Genes Chromosomes Cancer 1992, 4:337-342.
6. Rutkowski JL, Wu K, Gutmann DH, Boyer PJ, Legius E: Genetic and cellular defects contributing to benign tumor formation in neurofibromatosis type 1. Hum Mol Genet 2000, 9:1059-1066.
7. Sawada S, Florell S, Purandare SM, Ota M, Stephens K, Viskochil D: Identification of NF1 mutations in both alleles of a dermal neurofibroma. Nat Genet 1996, 14:110-112.
8. Serra E, Puig S, Otero D, Gaona A, Kruyer H, Ars E, Estivill X, Lazaro C: Confirmation of a double-hit model for the NF1 gene in benign neurofibromas. Am J Hum Genet 1997, 61:512-519.
9. Garbe C, Blum A: Epidemiology of cutaneous melanoma in Germany and worldwide. Skin Pharmacol Appl Skin Physiol 2001, 14:280-290.
10. De Schepper S, Boucneau J, Lambert J, Messiaen L, Naeyaert JM: Pigment cell-related manifestations in neurofibromatosis type 1: an overview. Pigment Cell Res 2005, 18:13-24.
11. Guillot B, Dalac S, Delaunay M, Baccard M, Chevrant-Breton J, Dereure O, Machet L, Sassolas B, Zeller J, Bernard P, Bedane C, Wolkenstein P, French Group of Cutaneous Oncology: Cutaneous malignant melanoma and neurofibromatosis type 1. Melanoma Res 2004, 14:159-163.
12. Gutzmer R, Herbst RA, Mommert S, Kiehl P, Matiaske F, Rutten A, Kapp A, Weiss J: Allelic loss at the neurofibromatosis type 1 (NF1) gene locus is frequent in desmoplastic neurotropic melanoma. Hum Genet 2000, 107:357-361.
13. Ishii S, Han S, Shiiba K, Mizoi T, Okabe M, Horii A, Nagura H, Matsuno S, Sasaki I: Allelic loss of the NF1 gene in anal malignant melanoma in a patient with neurofibromatosis type 1. Int J Clin Oncol 2001, 6:201-204.
14. Rübben A, Kempf W, Kadin ME, Zimmermann DR, Burg G: Multilineage progression of genetically unstable tumor subclones in cutaneous T-cell lymphoma. Exp Dermatol 2004, 13:472-483.
15. Vogelstein B, Kinzler KW: Digital PCR. Proc Natl Acad Sci USA 1999, 96:9236-9241.
16. Zhou W, Galizia G, Lieto E, Goodman SN, Romans KE, Kinzler KW, Vogelstein B, Choti MA, Montgomery EA: Counting alleles reveals a connection between chromosome 18q loss and vascular invasion. Nat Biotechnol 2001, 19:78-81.
17. Liu J, Zabarovska VI, Braga E, Alimov A, Klein G, Zabarovsky ER: Loss of heterozygosity in tumor cells requires re-evaluation: the data are biased by the size-dependent differential sensitivity of allele detection. FEBS Lett 1999, 462:121-128.
18. Farrand K, Jovanovic L, Delahunt B, McIver B, Hay ID, Eberhardt NL, Grebe SK: Loss of heterozygosity studies revisited: prior quantification of the amplifiable DNA content of archival samples improves efficiency and reliability. J Mol Diagn 2002, 4:150-158.
19. National Institutes of Health Consensus Development Conference: Neurofibromatosis conference statement. Arch Neurol 1988, 45:575-578.
20. Fahsold R, Hoffmeyer S, Mischung C, Gille C, Ehlers C, Kucukceylan N, Abdel-Nour M, Gewies A, Peters H, Kaufmann D, Buske A, Tinschert S, Numberg P: Minor lesion mutational spectrum of the entire NF1 gene does not explain its high mutability but points to a functional domain upstream of the GAP-related domain. Am J Hum Genet 2000, 66:790-818.
21. Messiaen LM, Callens T, Mortier G, Beysen D, Vandenbroucke I, Van Roy N, Speleman F, Paepe AD: Exhaustive mutation analysis of the NF1 gene allows identification of 95% of mutations and reveals a high frequency of unusual splicing defects. Hum Mutat 2000, 15:541-55.
22. Ars E, Kruyer H, Morell M, Pros E, Serra E, Ravella A, Estivill X, Lazaro C: Recurrent mutations in the NF1 gene are common among neurofibromatosis type 1 patients. J Med Genet 2003, 40:e82.
23. Traverso G, Shuber A, Olsson L, Levin B, Johnson C, Hamilton SR, Boynton K, Kinzler KW, Vogelstein B: Detection of proximal colorectal cancers through analysis of faecal DNA. Lancet 2002, 359:403-404.
24. Pohl G, Shih IM: Principle and applications of digital PCR. Expert Rev Mol Diagn 2004, 4:41-47.
25. Knudson AGJr: Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci USA 1971, 68:820-823.
26. De Schepper S, Boucneau JM, Westbroek W, Mommaas M, Onderwater J, Messiaen L, Naeyaert JM, Lambert JL: Neurofibromatosis type 1 protein and amyloid precursor protein interact in normal human melanocytes and colocalize with melanosomes. J Invest Dermatol 2006, 126:653-659.
27. De Schepper S, Boucneau J, Vander Haeghen Y, Messiaen L, Naeyaert JM, Lambert J: Cafe-au-lait spots in neurofibromatosis type 1 and in healthy control individuals: hyperpigmentation of a different kind? Arch Dermatol Res 2006, 297:439-449.
28. Kaufmann D, Wiandt S, Veser J, Krone W: Increased melanogenesis in cultured epidermal melanocytes from patients with neurofibromatosis 1 (NF 1). Hum Genet 1991, 87:144-150.
29. Eisenbarth I, Assum G, Kaufmann D, Krone W: Evidence for the presence of the second allele of the neurofibromatosis type 1 gene in melanocytes derived from cafe au lait macules of NF1 patients. Biochem Biophys Res Commun 1997, 237:138-141.
30. Yoshida H, Kunisada T, Kusakabe M, Nishikawa S, Nishikawa SI: Distinct stages of melanocyte differentiation revealed by anlaysis of nonuniform pigmentation patterns. Development 1996, 122:1207-1214.
31. Wilkie AL, Jordan SA, Jackson IJ: Neural crest progenitors of the melanocyte lineage: coat colour patterns revisited. Development 2002, 129:3349-3357.
32. Nishimura EK, Jordan SA, Oshima H, Yoshida H, Osawa M, Moriyama M, Jackson IJ, Barrandon Y, Miyachi Y, Nishikawa S: Dominant role of the niche in melanocyte stem-cell fate determination. Nature 2002, 416:854-860.
33. Gruber SB, Barnhill RL, Stenn KS, Roush GC: Nevomelanocytic proliferations in association with cutaneous malignant melanoma: a multivariate analysis. J Am Acad Dermatol 1989, 21:773-780.
34. Cramer SF: The origin of epidermal melanocytes. Implications for the histogenesis of nevi and melanomas. Arch Pathol Lab Med 1991, 115:115-119.
35. Krengel S: Nevogenesis - new thoughts regarding a classical problem. Am J Dermatopathol 2005, 27:456-465.
36. Cramer SF: The histogenesis of acquired melanocytic nevi. Based on a new concept of melanocytic differentiation. Am J Dermatopathol 1984, 6 Suppl:289-298.
37. Yang P, Hirose T, Hasegawa T, Seki K, Nakanishi H, Hizawa K: Ultrastructural heterogeneity of acquired intradermal melanocytic nevus cells. Ultrastruct Pathol 1996, 20:255-261.
38. Busam KJ: Cutaneous desmoplastic melanoma. Adv Anat Pathol 2005, 12:92-102.
39. Winnepenninckx V, De Vos R, Stas M, van den Oord JJ: New phenotypical and ultrastructural findings in spindle cell (desmoplastic/neurotropic) melanoma. Appl Immunohistochem Mol Morphol 2003, 11:319-325.
40. Curtin JA, Fridlyand J, Kageshita T, Patel HN, Busam KJ, Kutzner H, Cho KH, Aiba S, Bröcker EB, LeBoit PE, Pinkel D, Bastian BC: Distinct sets of genetic alterations in melanoma. N Engl J Med 2005, 353:2135-2147.
41. Davies H, Bignell GR, Cox C, Stephens P, Edkins S, Clegg S, Teague J, Woffendin H, Garnett MJ, Bottomley W, Davis N, Dicks E, Ewing R, Floyd Y, Gray K, Hall S, Hawes R, Hughes J, Kosmidou V, Menzies A, Mould C, Parker A, Stevens C, Watt S, Hooper S, Wilson R, Jayatilake H, Gusterson BA, Cooper C, Shipley J, Hargrave D, Pritchard-Jones K, Maitland N, Chenevix-Trench G, Riggins GJ, Bigner DD, Palmieri G, Cossu A, Flanagan A, Nicholson A, Ho JW, Leung SY, Yuen ST, Weber BL, Seigler HF, Darrow TL, Paterson H, Marais R, Marshall CJ, Wooster R, Stratton MR, Futreal PA: Mutations of the BRAF gene in human cancer. Nature 2002, 417:949-954.
42. Pollock PM, Harper UL, Hansen KS, Yudt LM, Stark M, Robbins CM, Moses TY, Hostetter G, Wagner U, Kakareka J, Salem G, Pohida T, Heenan P, Duray P, Kallioniemi O, Hayward NK, Trent JM, Meltzer PS: High frequency of BRAF mutations in nevi. Nat Genet 2003, 33:19-20.
43. The Genome Database [http://www.gdb.org]
44. Royal R: Statistical evidence: A likelihood primer London: Chapman and Hall; 1997.